Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02942368 · ClinicalTrials.gov registry record · NA
Adaptive tDCS for Treatment-Resistant MDD
A NA study of Depressive Disorder, Treatment-Resistant, sponsored by Washington University School of Medicine.
- Active
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT02942368 is a NA study of Depressive Disorder, Treatment-Resistant that is active but no longer recruiting, run by Washington University School of Medicine. The registered enrollment target is 25 participants, below the 235-participant average among 9 other Depressive Disorder, Treatment-Resistant trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02942368, a NA study of Depressive Disorder, Treatment-Resistant, is active but no longer recruiting, sponsored by Washington University School of Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot study aims to investigate the potential role of transcranial direct current stimulation (tDCS) in the treatment of treatment-resistant major depressive disorder (MDD). tDCS is a noninvasive brain stimulation technique which has been utilized for the treatment of major depression in several studies, both as a primary and adjunctive treatment. The treatment will be administered under the supervision of a physician with experience in administering the treatment and monitoring for complications. This will be a prospective "adaptive tDCS stimulation" open label research study. Participants will receive 20 minute sessions of up to 4 milliamps (mA) transcutaneous electrical stimulation sessions over 4 to 6 weeks. Building on the theory that greater current "dose" may be a significant factor in determining efficacy, this study aims to determine whether higher tDCS current doses lead to greater improvements in depressive symptoms in this population of patients with treatment-resistant major depressive disorder.
Conditions Studied
Interventions
- DEVICE tDCS
Study Locations (1)
Missouri
- Washington University in Saint Louis - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-04-14 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02942368
The ClinicalTrials.gov registry entry for NCT02942368 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 235-participant average among 9 other Depressive Disorder, Treatment-Resistant trials with a reported enrollment target (89% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Depressive Disorder, Treatment-Resistant appearing as the primary indexed condition, and to 1 intervention - of which tDCS is the first listed.
NCT02942368 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT02942368 about?
NCT02942368 is a clinical study titled "Adaptive tDCS for Treatment-Resistant MDD". This pilot study aims to investigate the potential role of transcranial direct current stimulation (tDCS) in the treatment of treatment-resistant major depressive disorder (MDD). tDCS is a noninvasive brain stimulation technique which has been utilized for the treatment of major depression in severa...
What is the current status of trial NCT02942368?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2017-04-14. Estimated completion is 2027-12.
What conditions does trial NCT02942368 study?
This clinical trial studies the following conditions: Depressive Disorder, Treatment-Resistant.
What interventions are being tested in trial NCT02942368?
The interventions under investigation include: tDCS (DEVICE).
Who is sponsoring clinical trial NCT02942368?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02942368 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depressive Disorder, Treatment-Resistant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)
COMPLETED · NA
-
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
RECRUITING · Phase 2
-
Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
RECRUITING · Phase 2
-
Intravenous Ketamine for Treatment-Resistant Depression
RECRUITING · Phase 2
-
Improving Brain Stimulation Through Imaging
ACTIVE NOT RECRUITING
-
Dopaminergic Dysfunction in Late-Life Depression
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.